GlassScriptPhysician profile
Carol A Lund
NPI 1235379363
$2,349.47
in general payments reported to CMS, 2019-2025
31 companies · $88.71 in 2025
The $88.71 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $679 · 2022: $509 · 2023: $636 · 2024: $438 · 2025: $88.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,132 · Education: $16.27 · Entertainment: $13.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.83 |
| Education | $16.27 |
| Entertainment | $13.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $542.27 | 2021-2025 | |
| Novo Nordisk INC | $403.85 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $334.37 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $125.23 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $112.60 | 2022-2024 | Farxiga, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.27 | 2021-2025 | Xifaxan |
| Abbott Laboratories | $100.06 | 2021-2024 | Freestyle Libre 3 |
| Daiichi Sankyo INC. | $56.60 | 2024 | Injectafer |
| Inspire Medical Systems, INC. | $55.74 | 2024 | Inspire |
| Novartis Pharmaceuticals Corporation | $45.42 | 2022-2024 | |
| Edwards Lifesciences Corporation | $39.78 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Esperion Therapeutics, INC. | $39.47 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $38.25 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $35.34 | 2023-2024 | Austedo Xr |
| Dexcom, INC. | $31.73 | 2024 | Dexcom G6 Transmitter |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.31 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $25.52 | 2023 | Opsumit |
| Boston Scientific Corporation | $23.40 | 2024 | Watchman Flx |
| Otsuka America Pharmaceutical, INC. | $21.88 | 2023 | Rexulti |
| Glaxosmithkline, LLC. | $18.49 | 2021 | |
| Philips North America LLC | $18.42 | 2024 | (Ck6) Holter |
| Amarin Pharma, INC. | $18.22 | 2021 | |
| Amgen INC. | $16.31 | 2021 | |
| Merck Sharp & Dohme LLC | $16.14 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.70 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.39 | 2022 | |
| Medtronic, INC. | $14.57 | 2024 | Closurefast |
| Optos, INC. | $13.82 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Astellas Pharma US INC | $13.47 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.02 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.83 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Lund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.